InvestSMART

Emerald Resources NL (ASX: EMR) - Announcements

Current share price for EMR : $6.900 0.16 (2.27%)+

ASX company news and announcements for Emerald Resources NL (EMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emerald Resources NL (EMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emerald Resources NL (EMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emerald Resources NL (EMR)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$4,578 Ceasing to be a substantial holder 21 Nov 2024 6:14PM $3.670 $6.900 risen by 88.01%
$4,578 Becoming a substantial holder 20 Nov 2024 6:26PM $3.590 $6.900 risen by 92.20%
$4,578 Application for quotation of securities - EMR 4 Nov 2024 7:38PM $4.220 $6.900 risen by 63.51%
$4,578 Option Exercise 4 Nov 2024 7:33PM $4.220 $6.900 risen by 63.51%
$4,578 Quarterly Report 31 Oct 2024 9:09AM $4.190 $6.900 risen by 64.68%
$4,578 EMR Continues Exploration Success in Australia and Cambodia 30 Oct 2024 9:15AM $4.210 $6.900 risen by 63.90%
$4,578 Golden Horse Minerals Priority Offer to Emerald Shareholders 29 Oct 2024 8:03PM $4.210 $6.900 risen by 63.90%
$4,578 Annual Report to shareholders 18 Oct 2024 2:45PM $4.205 $6.900 risen by 64.09%
$4,578 Letter to Shareholders - AGM Materials 18 Oct 2024 2:41PM $4.205 $6.900 risen by 64.09%
$4,578 Notice of Annual General Meeting/Proxy Form 18 Oct 2024 2:37PM $4.215 $6.900 risen by 63.70%
$4,578 Notification regarding unquoted securities - EMR 8 Oct 2024 7:01PM $3.770 $6.900 risen by 83.02%
$4,578 September Quarterly Production Guidance Achieved 8 Oct 2024 9:32AM $3.730 $6.900 risen by 84.99%
$4,578 Prominent Industry Leader Simon Lee AO Announces Retirement 3 Oct 2024 10:08AM $3.790 $6.900 risen by 82.06%
$4,578 Date of Annual General Meeting 2 Oct 2024 4:54PM $3.800 $6.900 risen by 81.58%
$4,578 Pit Access Restored at Okvau Well Ahead of Schedule 30 Sep 2024 9:29AM $4.000 $6.900 risen by 72.50%
$4,578 Application for quotation of securities - EMR 17 Sep 2024 6:59PM $3.870 $6.900 risen by 78.29%
$4,578 Option Exercise 17 Sep 2024 6:58PM $3.870 $6.900 risen by 78.29%
$4,578 Production Guidance Unchanged Following Minor Wall Slip 16 Sep 2024 9:11AM $4.080 $6.900 risen by 69.12%
$4,578 Option Exercise 11 Sep 2024 6:42PM $3.830 $6.900 risen by 80.16%
$4,578 Application for quotation of securities - EMR 11 Sep 2024 6:40PM $3.830 $6.900 risen by 80.16%
$4,578 Application for quotation of securities - EMR 4 Sep 2024 6:36PM $3.760 $6.900 risen by 83.51%
$4,578 Option Exercise 4 Sep 2024 6:34PM $3.760 $6.900 risen by 83.51%
$4,578 Emerald to Cornerstone Golden Horse Minerals Dual Listing 4 Sep 2024 9:47AM $3.850 $6.900 risen by 79.22%
$4,578 Appendix 4G 30 Aug 2024 9:00AM $3.900 $6.900 risen by 76.92%
$4,578 Annual Report and Appendix 4E 30 Aug 2024 8:51AM $3.900 $6.900 risen by 76.92%

201 - 225 of 1040 results

Page 9 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.